Patents Assigned to Invitrogen Corporation
  • Publication number: 20080261308
    Abstract: The present invention relates to nutritive medium, medium supplement, media subgroup and buffer formulations. The present invention provides powder nutritive medium, medium supplement and medium subgroup formulations, e.g., cell culture medium supplements (including powdered sera such as powdered fetal bovine serum (FBS)), medium subgroup formulations and cell culture media comprising all of the necessary nutritive factors that facilitate the in vitro cultivation of cells. The invention further provides powder buffer formulations that produce particular ionic and pH conditions upon reconstitution with a solvent. The invention provides methods for production of media, media supplement, media subgroup and buffer formulations, and also provides kits and methods for cultivation of prokaryotic and eukaryotic cells, particularly bacterial cells, yeast cells, plant cells and animal cells (including human cells) using these dry powder nutritive media, media supplement, media subgroup and buffer formulations.
    Type: Application
    Filed: January 22, 2008
    Publication date: October 23, 2008
    Applicant: INVITROGEN CORPORATION
    Inventors: Richard M. Fike, William Whitford, Richard F. Hassett, Jeffrey W. Biddle, Laurel Biddle, Christine M. Biddle, Robert C. Radominski, Barbara M. Dadey
  • Publication number: 20080261202
    Abstract: Polyfunctional reagents are disclosed that are capable of reversibly binding to target substances, for example nucleic acid, proteins, polypeptides, cells, cell components, microorganisms or viruses, for use in purifying or otherwise manipulating them. The reagents comprise a tagging group for manipulating and/or detecting the target substance when bound to the polyfunctional reagent. The polyfunctional reagents work by binding the target substance at a first pH and then releasing it at a second pH, usually higher than the first. Examples of tagging groups include tagging group members of a specific binding pair which is capable of binding to a specific binding partner and/or a label.
    Type: Application
    Filed: March 27, 2008
    Publication date: October 23, 2008
    Applicant: INVITROGEN CORPORATION
    Inventors: Matthew Baker, Simon Douglas, Elliot Lawrence
  • Publication number: 20080254501
    Abstract: Chemical stain compounds containing a fluorophore and a reducible quenching unit are disclosed. The reducible quenching unit quenches the fluorophore while in its oxidized state. Upon reduction, the quenching properties of the quenching unit are diminished or eliminated. The chemical compounds can be used in a variety of applications, including the detection of bacterial cells, monitoring the electron transport chain function of bacterial cells, monitoring the oxidation state of non-biological systems, and assaying the effectiveness of antibacterial or antimicrobial agents.
    Type: Application
    Filed: October 10, 2007
    Publication date: October 16, 2008
    Applicant: INVITROGEN CORPORATION
    Inventors: Ching-Ying Cheung, Diane R. Gray, Stephen T. Yue
  • Publication number: 20080254481
    Abstract: Provided herein are novel autoantibody biomarkers, and panels for detecting autoantibody biomarkers for prostate cancer, and methods and kits for detecting these biomarkers in the serum of individuals suspected of having prostate cancer.
    Type: Application
    Filed: November 13, 2007
    Publication date: October 16, 2008
    Applicant: INVITROGEN CORPORATION
    Inventors: Bradley Love, Jeffrey Rogers, Joseph Beechem, Lilin Wang
  • Publication number: 20080254525
    Abstract: A thermostable DNA polymerase composition comprising at least two DNA polymerases, one of which is substantially reduced in 5?-exonuclease activity and one of which has 5?-exonuclease activity.
    Type: Application
    Filed: March 20, 2008
    Publication date: October 16, 2008
    Applicant: INVITROGEN CORPORATION
    Inventors: Weidong Zheng, Jun E. Lee, Robert Jason Potter, David Mandelman
  • Publication number: 20080254482
    Abstract: Provided herein are novel panels of biomarkers for the diagnosis of autoimmune diseases, and methods and kits for detecting these biomarkers in samples of individuals suspected of having an autoimmune disease. Also provided are methods of monitoring the progression of an autoimmune disease and methods of monitoring the efficacy and side effects of a treatment for an autoimmune disease.
    Type: Application
    Filed: November 21, 2007
    Publication date: October 16, 2008
    Applicant: Invitrogen Corporation
    Inventors: Dawn R. Mattoon, Barry Schweitzer, David Alcorta, Dhavalkumar Patel, Ronald Falk
  • Publication number: 20080248565
    Abstract: Systems and methods are provided for producing a protein of interest that is typically not amenable to expression in soluble form in in vitro expression systems. In some aspects, the invention provides methods of synthesizing proteins using in vitro protein synthesis systems that include a scaffold protein such as apolipoprotein or an amphipathic alpha helix containing (“AAHC”) protein, in which higher yields of soluble protein are produced than in the absence of the scaffold protein. The scaffold proteins may be provided in an in vitro protein synthesis system associated with lipid or not associated with lipid. The scaffold protein may be provided as a protein per se or may be encoded by a nucleic acid template and co-expressed with the protein of interest. The invention also provides compositions and kits for synthesis of proteins in soluble form, in which the compositions and kits include cell extracts for protein expression and isolation.
    Type: Application
    Filed: February 29, 2008
    Publication date: October 9, 2008
    Applicant: INVITROGEN CORPORATION
    Inventors: Federico Katzen, Julia Fletcher, Wieslaw Kudlicki, Joseph Beechem, Lilin Wang
  • Publication number: 20080248516
    Abstract: Division arrested cells are used in screening assays to determine the effect of a substance of interest on the cells. The division arrested cells can be used in drug screening assays, signal transduction assays, and are especially useful in large scale, high throughput assays.
    Type: Application
    Filed: June 12, 2008
    Publication date: October 9, 2008
    Applicant: INVITROGEN CORPORATION
    Inventors: Thomas Livelli, Zhong Zhong, Mark Federici, Mei Cong
  • Publication number: 20080248971
    Abstract: An interactive method of providing an array of nucleic acid sequences in which a remote user enters a query to generate a listing of desired sequence probes, which are then selected and returned to the host for use in producing a custom microarray designed by a remote user.
    Type: Application
    Filed: March 10, 2008
    Publication date: October 9, 2008
    Applicant: INVITROGEN CORPORATION
    Inventors: Xiaolian Gao, Xiaoming Wang, Jerry Liu
  • Patent number: 7432372
    Abstract: The invention provides novel fluorinated resorufin compounds that are of use in a variety of assay formats. Also provided are methods of using the compounds and kits that include a compound of the invention and instructions detailing the use of the compound in one or more assay formats.
    Type: Grant
    Filed: November 1, 2004
    Date of Patent: October 7, 2008
    Assignee: Invitrogen Corporation
    Inventors: Robert Hardy Batchelor, Yue Ge, Iain D. Johnson, Wai-Yee Leung, Jixiang Liu, Brian Patch, Peter Aaron Emrys Smalley, Thomas Harry Steinberg
  • Publication number: 20080241889
    Abstract: The present invention provides compositions and methods for recombinational cloning. The compositions include vectors having multiple recombination sites and/or multiple topoisomerase recognition sites. The methods permit the simultaneous cloning of two or more different nucleic acid molecules. In some embodiments the molecules are fused together while in other embodiments the molecules are inserted into distinct sites in a vector. The invention also generally provides for linking or joining through recombination a number of molecules and/or compounds (e.g., chemical compounds, drugs, proteins or peptides, lipids, nucleic acids, carbohydrates, etc.) which may be the same or different.
    Type: Application
    Filed: December 18, 2006
    Publication date: October 2, 2008
    Applicant: INVITROGEN CORPORATION
    Inventors: Jonathan D. Chesnut, John Carrino, Louis Leong, Knut Madden, Martin A.G. Gleeson, James Fan, Michael A. Brasch, David Cheo, James L. Hartley, Devon R.N. Byrd, Gray F. Temple
  • Publication number: 20080237043
    Abstract: The invention provides methods, apparatus and kits for integrally labeling polymeric gels, such as polyacrylamide and agarose gels, with indicia that can serve, inter alia, unambiguously to identify the individual gel, using polymeric film labeled with detectable indicia and coated with materials that bond to the gel matrix as the gel polymerizes.
    Type: Application
    Filed: February 28, 2008
    Publication date: October 2, 2008
    Applicant: INVITROGEN CORPORATION
    Inventors: Joseph W. Amshey, Allen Bautista
  • Publication number: 20080241375
    Abstract: Water-dispersible nanoparticles are prepared by applying a coating of a multiply amphipathic dispersant to the surface of a hydrophobic nanoparticle comprised of a semiconductive or metallic material. The multiply amphipathic dispersant has two or more hydrophobic regions and two or more hydrophilic regions, and is typically polymeric. Preferred polymeric dispersants are comprised of (1) a hydrophobic backbone with hydrophilic branches, (2) a hydrophilic backbone with hydrophobic branches, or (3) a backbone that may be either hydrophobic or hydrophilic, and substituted with both hydrophilic and hydrophobic branches. Monodisperse populations of water-dispersible nanoparticles are also provided, as are conjugates of the water-dispersible nanoparticles with affinity molecules such as peptides, oligonucleotides, and the like.
    Type: Application
    Filed: January 11, 2008
    Publication date: October 2, 2008
    Applicant: INVITROGEN CORPORATION
    Inventors: Edward William Adams, Marcel Bruchez Pierre
  • Publication number: 20080227107
    Abstract: The present invention is generally related to compositions, kits and methods for labeling nucleic acid molecules using reverse transcriptases, preferably multi-subunit reverse transcriptases such as ASLV reverse transcriptases. Specifically, the invention relates to methods, kits and compositions for fluorescently labeling nucleic acid molecules during nucleic acid synthesis. The labeled nucleic acid molecules produced in accordance with the invention are particularly suited as labeled probes for nucleic acid detection and diagnostics.
    Type: Application
    Filed: April 29, 2008
    Publication date: September 18, 2008
    Applicant: INVITROGEN CORPORATION
    Inventors: Christian E. Gruber, Po-Jen Shih
  • Publication number: 20080213919
    Abstract: Functionalized fluorescent nanocrystal compositions and methods for making and using these compositions are disclosed. The compositions are fluorescent nanocrystals coated with at least one material. The coating material has chemical compounds or ligands with functional groups or moieties with conjugated electrons and moieties for imparting solubility to coated fluorescent nanocrystals in aqueous solutions. The coating material provides for functionalized fluorescent nanocrystal compositions which are water soluble, chemically stable, and emit light with a high quantum yield and/or luminescence efficiency when excited with light. The coating material may also have chemical compounds or ligands with moieties for bonding to target molecules and cells as well as moieties for cross-linking the coating.
    Type: Application
    Filed: March 3, 2008
    Publication date: September 4, 2008
    Applicant: INVITROGEN CORPORATION
    Inventor: Imad Naasani
  • Publication number: 20080213811
    Abstract: The present invention relates to biosensors. In some embodiments, the biosensors are modified ligand binding molecules. In some embodiments, the modified ligand binding molecule is a phosphate binding protein (PBP). In some embodiments, the modified ligand binding molecules are labeled to be capable of RET, e.g., comprising a donor and acceptor moiety. In some embodiments of the invention, there is a detectable change in RET (e.g., FRET) when the modified ligand binding molecule binds and/or releases the ligand (e.g., phosphate). The invention also provides related methods, reactions and assays.
    Type: Application
    Filed: August 10, 2007
    Publication date: September 4, 2008
    Applicant: Invitrogen Corporation
    Inventors: Kurt Vogel, Rhonda Newman, Steven Riddle
  • Publication number: 20080216185
    Abstract: The disclosure relates generally to stem cell biology and more specifically to genetic manipulation of stem cells. Methods and compositions using recombinational cloning techniques are disclosed which allow the construction and insertion of complex genetic constructs into embryonic and adult stem cells and progenitor cells. The methods disclosed will allow the harvesting of adult stem cells pre-engineered with integration sites to facilitate early passage genetic modification.
    Type: Application
    Filed: January 18, 2008
    Publication date: September 4, 2008
    Applicant: INVITROGEN CORPORATION
    Inventors: Jonathan CHESNUT, Antje Taliana, Bhaskar Thyagarajan, Mahendra Rao, Pauline Lieu, Robert Bennett, Robert Burrier
  • Publication number: 20080207776
    Abstract: The present invention discloses highly packed polycationic ammonium, sulfonium and phosphonium lipid compounds useful for making lipid aggregates for delivery of macromolecules and other compounds into cells. They are especially useful for the DNA-dependent transformation of cells. Methods for their preparation and use as intracellular delivery agents are also disclosed.
    Type: Application
    Filed: October 31, 2007
    Publication date: August 28, 2008
    Applicant: INVITROGEN CORPORATION
    Inventors: Alberto Haces, Valentina C. Ciccarone
  • Publication number: 20080199875
    Abstract: Embodiments of the present invention provide methods and nucleic acid reporter molecules for the detection of nucleic acid in a sample. The nucleic acid reporter molecule comprises two unsymmetrical cyanine monomer moieties, which may be the same or different, that are covalently attached by a linker comprising at least one aromatic, heteroaromatic, cyclic or heterocyclic moiety comprising 3-20 non-hydrogen atoms selected from the group consisting of O, N, S, P and C. The linker may be rigid, relatively flexible or some degree thereof. The unsymmetrical cyanine monomer moieties comprise a substituted or unsubstituted benzazolium moiety and a substituted or unsubstituted pyridinium or quinolinium moiety that is connected by a methine bridge that is monomethine, trimethine or pentamethine. The linkers form the cyanine dimer compounds by attaching to the pyridinium or quinolinium moiety of the monomer moieties.
    Type: Application
    Filed: April 7, 2008
    Publication date: August 21, 2008
    Applicant: INVITROGEN CORPORATION
    Inventors: Stephen Yue, Ching-Ying Cheung
  • Patent number: 7408049
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Grant
    Filed: July 19, 2004
    Date of Patent: August 5, 2008
    Assignee: Invitrogen Corporation
    Inventors: James L. Hartley, Michael A. Brasch, Gary F. Temple, Donna K. Fox